A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

Overview of attention for article published in BMC Cancer, July 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 15,232 followers.

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical... http://t.co/RZmpA6QCPj #bmccancer

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical ... http://t.co/K4ZUvuFAAo #cancer

◈ A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tu... http://t.co/zo2tmh6bRg ◈

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.